Shattuck Labs, Inc. (STTK)
3.14
+0.13
(+4.32%)
USD |
NASDAQ |
Dec 09, 16:00
3.15
+0.01
(+0.32%)
After-Hours: 20:00
Shattuck Labs EPS Diluted (Quarterly): -0.1393 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.06M |
| Revenue (Quarterly) | 1.00M |
| Total Expenses (Quarterly) | 11.06M |
| Enterprise Value | 115.20M |
| Gross Profit Margin (Quarterly) | 8.30% |
| Profit Margin (Quarterly) | -1.01K% |
| Earnings Yield | -32.48% |
| Normalized Earnings Yield | -32.45 |